Literature DB >> 20431044

P413L CHGB is not associated with ALS susceptibility or age at onset in a Dutch population.

Paul W J van Vught, Jan H Veldink, Leonard H van den Berg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20431044      PMCID： PMC2889321          DOI： 10.1073/pnas.1002512107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

Review 1.  Why most discovered true associations are inflated.

Authors:  John P A Ioannidis
Journal:  Epidemiology       Date:  2008-09       Impact factor: 4.822

2.  Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.

Authors:  Francois Gros-Louis; Peter M Andersen; Nicolas Dupre; Makoto Urushitani; Patrick Dion; Frederique Souchon; Monique D'Amour; William Camu; Vincent Meininger; Jean-Pierre Bouchard; Guy A Rouleau; Jean-Pierre Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

3.  Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis.

Authors:  Michael A van Es; Caroline Dahlberg; Anna Birve; Jan Herman Veldink; Leonard H van den Berg; P M Andersen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12-03       Impact factor: 10.154

4.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

5.  Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.

Authors:  Michael A van Es; Jan H Veldink; Christiaan G J Saris; Hylke M Blauw; Paul W J van Vught; Anna Birve; Robin Lemmens; Helenius J Schelhaas; Ewout J N Groen; Mark H B Huisman; Anneke J van der Kooi; Marianne de Visser; Caroline Dahlberg; Karol Estrada; Fernando Rivadeneira; Albert Hofman; Machiel J Zwarts; Perry T C van Doormaal; Dan Rujescu; Eric Strengman; Ina Giegling; Pierandrea Muglia; Barbara Tomik; Agnieszka Slowik; Andre G Uitterlinden; Corinna Hendrich; Stefan Waibel; Thomas Meyer; Albert C Ludolph; Jonathan D Glass; Shaun Purcell; Sven Cichon; Markus M Nöthen; H-Erich Wichmann; Stefan Schreiber; Sita H H M Vermeulen; Lambertus A Kiemeney; John H J Wokke; Simon Cronin; Russell L McLaughlin; Orla Hardiman; Katsumi Fumoto; R Jeroen Pasterkamp; Vincent Meininger; Judith Melki; P Nigel Leigh; Christopher E Shaw; John E Landers; Ammar Al-Chalabi; Robert H Brown; Wim Robberecht; Peter M Andersen; Roel A Ophoff; Leonard H van den Berg
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330
  5 in total
  1 in total

1.  Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.

Authors:  Yasuyuki Ohta; Genevieve Soucy; Daniel Phaneuf; Jean-Nicolas Audet; François Gros-Louis; Guy A Rouleau; Hélène Blasco; Philippe Corcia; Peter M Andersen; Frida Nordin; Toru Yamashita; Koji Abe; Jean-Pierre Julien
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.